Publication | Open Access

Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)

Advanced Cervical CancerCervical Cancer ManagementPatient-reported OutcomesCervical CancerCervical HealthMedicineCancer ManagementClinical TrialsGynecologyCancer TreatmentOncologyGynecology OncologyHealth Sciences